Multicenter Study Into Individualized Scanning for Coronary Artery Disease

NCT ID: NCT04837846

Last Updated: 2024-11-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-29

Study Completion Date

2024-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate intravascular attenuation of the coronary arteries and image quality in an individualized scan and CM injection protocol whereas both scan and injection parameters are tailored to the individual patient in a North American, European and Asian patient population.

To evaluate the radiation dose and contrast media dose of this individualized approach for CCTA in an American, European and Chinese patient population.

To evaluate the injection parameters required for an average American, European and Chinese patient population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prospective CCTA Arm

Differing Tube Voltage Administration

Intervention Type OTHER

Subjects will undergo CCTA utilizing a scan and contrast media injection protocol that will be tailored to individual body habitus.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Differing Tube Voltage Administration

Subjects will undergo CCTA utilizing a scan and contrast media injection protocol that will be tailored to individual body habitus.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To be eligible for the study: (All answers must be "YES" for subject to be eligible.)

1. Referred for a clinically indicated CCTA scan.
2. Patient aged older than 18.
3. Subject must provide written informed consent prior to any study-related procedures being performed.
4. Subject must be willing to comply with all clinical study procedures.
5. Atypical or typical complaints of angina.
6. No previous cardiovascular history.
7. Possibility of 'flash' mode scan; patient heart rate below 70 beats per minute and regular rhythm.

Exclusion Criteria

* The presence of the following excludes subjects from the study: (All answers must be "NO" for subject to be eligible.)

1. Contraindications for CT coronary angiography, including:

1. Inability to perform a breath hold for at least the expected scan time
2. Unstable angina
3. Hemodynamic instability
4. Known history of CAD
5. Pregnancy
6. Renal insufficiency (defined as Creatinine \<1.5 mg/dL or GFR\<30 mL/min)
7. Iodine allergy
2. Insufficient cannula venous access (preferred 18G, minimal 20G cannula)
3. Subject has an acute psychiatric disorder.
4. Subject is unwilling to comply with the requirements of the protocol.
5. Subject has previously entered this study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph U. Schoepf, MD

Role: PRINCIPAL_INVESTIGATOR

Medical University of South Carolina

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00093255

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.